Greg Jensen
2019
In 2019, Greg Jensen earned a total compensation of $689.2K as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $114,375 |
|---|---|
| Option Awards | $82,056 |
| Salary | $336,032 |
| Stock Awards | $93,558 |
| Other | $63,173 |
| Total | $689,194 |
Jensen received $336K in salary, accounting for 49% of the total pay in 2019.
Jensen also received $114.4K in non-equity incentive plan, $82.1K in option awards, $93.6K in stock awards and $63.2K in other compensation.
Rankings
In 2019, Greg Jensen's compensation ranked 10,743rd out of 13,971 executives tracked by ExecPay. In other words, Jensen earned more than 23.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,743 out of 13,971 | 23rd |
Division Manufacturing | 4,350 out of 5,701 | 24th |
Major group Chemicals And Allied Products | 1,692 out of 2,200 | 23rd |
Industry group Drugs | 1,448 out of 1,886 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 325 out of 389 | 17th |
Source: SEC filing on June 14, 2021.
Jensen's colleagues
We found two more compensation records of executives who worked with Greg Jensen at Xtant Medical Holdings in 2019.